BAL-1

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBAL-1
Drug Alias Nametricyclic topoisomerase inhibitors (Basilea Pharmaceutica/US Army Medical Research Institute of Infectious Diseases)BAL-1BAL-2
ClassificationSmall molecules
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsAnthraxTularemiaPlague +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnthraxTularemiaPlague +[5

Other Information

ATC CodeN/A
Related LinksN/A